BR112016011830A2 - synergistic bacterial compositions and methods for their production and use. - Google Patents
synergistic bacterial compositions and methods for their production and use.Info
- Publication number
- BR112016011830A2 BR112016011830A2 BR112016011830A BR112016011830A BR112016011830A2 BR 112016011830 A2 BR112016011830 A2 BR 112016011830A2 BR 112016011830 A BR112016011830 A BR 112016011830A BR 112016011830 A BR112016011830 A BR 112016011830A BR 112016011830 A2 BR112016011830 A2 BR 112016011830A2
- Authority
- BR
- Brazil
- Prior art keywords
- production
- methods
- bacterial compositions
- synergistic bacterial
- synergistic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361908702P | 2013-11-25 | 2013-11-25 | |
| US201361908698P | 2013-11-25 | 2013-11-25 | |
| US201462004187P | 2014-05-28 | 2014-05-28 | |
| PCT/US2014/067491 WO2015077794A1 (en) | 2013-11-25 | 2014-11-25 | Synergistic bacterial compositions and methods of production and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016011830A2 true BR112016011830A2 (en) | 2017-09-26 |
Family
ID=52278746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016011830A BR112016011830A2 (en) | 2013-11-25 | 2014-11-25 | synergistic bacterial compositions and methods for their production and use. |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10258655B2 (en) |
| EP (1) | EP3074027A1 (en) |
| JP (3) | JP6833514B2 (en) |
| KR (3) | KR102379658B1 (en) |
| CN (2) | CN105979952B (en) |
| AU (3) | AU2014352643A1 (en) |
| BR (1) | BR112016011830A2 (en) |
| CA (2) | CA3203756A1 (en) |
| MX (2) | MX367109B (en) |
| RU (1) | RU2722482C2 (en) |
| WO (1) | WO2015077794A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11167018B2 (en) | 2016-12-23 | 2021-11-09 | Keio University | Compositions and methods for the induction of CD8+ T-cells |
| US11723934B2 (en) | 2018-02-09 | 2023-08-15 | Keio University | Compositions and methods for the induction of CD8+ T-cells |
Families Citing this family (110)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| NZ607043A (en) | 2010-08-04 | 2015-05-29 | Borody Thomas J | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
| WO2012122478A1 (en) | 2011-03-09 | 2012-09-13 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| AU2013235340B2 (en) * | 2012-03-17 | 2019-05-23 | The Regents Of The University Of California | Fast diagnosis and personalized treatments for acne |
| US9719144B2 (en) | 2012-05-25 | 2017-08-01 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| EP3904502A3 (en) | 2013-02-04 | 2022-02-23 | Seres Therapeutics, Inc. | Compositions and methods |
| CN110917220A (en) | 2013-02-04 | 2020-03-27 | 赛里斯治疗公司 | Therapeutic compositions and methods of use thereof |
| JP6464142B2 (en) | 2013-03-14 | 2019-02-06 | セラバイオーム，エルエルシー | Targeted gastrointestinal delivery of probiotic organisms and / or therapeutic agents |
| AU2014232370B2 (en) * | 2013-03-15 | 2018-11-01 | Seres Therapeutics, Inc. | Network-based microbial compositions and methods |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| JP6637885B2 (en) | 2013-07-21 | 2020-01-29 | ペンデュラム セラピューティクス， インコーポレイテッド | Methods and systems for microbiome characterization, monitoring, and treatment |
| EP3035945B1 (en) * | 2013-08-22 | 2018-03-14 | Council of Scientific & Industrial Research | A probiotic composition comprising the novel isolated bacterial strain of brevibacterium casei ap9 |
| RU2722482C2 (en) | 2013-11-25 | 2020-06-01 | Серес Терапеутикс, Инк. | Synergistic bacterial compositions and methods for preparing and using them |
| US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| JP6868562B2 (en) | 2014-10-31 | 2021-05-19 | ペンデュラム セラピューティクス， インコーポレイテッド | Methods and compositions for microbial treatment and diagnosis of disorders |
| MA41020A (en) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND THEIR METHODS OF USE FOR MODULATION OF THE MICROBIOME |
| SG11201704811YA (en) | 2014-12-23 | 2017-07-28 | 4D Pharma Res Ltd | Immune modulation |
| BR112017013274A2 (en) | 2014-12-23 | 2018-02-06 | 4D Pharma Research Limited | polypeptide and immunomodulation |
| MX2017014488A (en) | 2015-05-14 | 2018-06-11 | Crestovo Holdings Llc | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them. |
| DK3297644T3 (en) | 2015-05-22 | 2022-04-11 | Univ Arizona State | Methods of treating autism spectrum disorder and associated symptoms |
| NZ737752A (en) | 2015-06-15 | 2022-02-25 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| MA41060B1 (en) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| CN115364122A (en) | 2015-06-15 | 2022-11-22 | 4D制药研究有限公司 | Compositions comprising bacterial strains |
| MA41010B1 (en) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| SI3307288T1 (en) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| AU2016102452A4 (en) * | 2015-06-23 | 2020-12-24 | Société des Produits Nestlé S.A. | Nutritional compositions and infant formulas containing oligofructose for reducing the load of pathogenic bacteria in the guts of infants and young children |
| EP3370748B1 (en) * | 2015-11-03 | 2022-06-08 | The Brigham and Women's Hospital, Inc. | Therapeutic microbiota for the treatment and/or prevention of food allergy |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| CN112569262A (en) | 2015-11-20 | 2021-03-30 | 4D制药研究有限公司 | Compositions comprising bacterial strains |
| GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| AU2016359178A1 (en) * | 2015-11-24 | 2018-06-14 | Seres Therapeutics, Inc. | Designed bacterial compositions |
| EP3379935A4 (en) * | 2015-11-25 | 2019-08-28 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for reducing vancomycin-resistantenterococci |
| CN106974940B (en) * | 2016-01-15 | 2020-08-25 | 深圳华大生命科学研究院 | Application of probiotics of scleritis in treating and preventing obesity and related diseases |
| EP4257194A3 (en) * | 2016-02-04 | 2023-12-20 | Universiteit Gent | Use of microbial communities for human and animal health |
| GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
| CN108883139B (en) | 2016-03-04 | 2022-04-26 | 4D制药有限公司 | Compositions comprising bacterial strains |
| CN109069558A (en) | 2016-03-04 | 2018-12-21 | 加利福尼亚大学董事会 | Microorganism consortium and application thereof |
| US11786562B2 (en) | 2016-04-19 | 2023-10-17 | Genome Research Limited | Bacteriotherapy |
| CA3021793A1 (en) | 2016-04-21 | 2017-10-26 | Naked Biome, Inc. | Compositions and methods for treatment of skin disorders |
| CN109562133A (en) * | 2016-06-14 | 2019-04-02 | 韦丹塔生物科学股份有限公司 | The treatment of clostridium difficile infection |
| US9999641B2 (en) | 2016-06-14 | 2018-06-19 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
| US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
| US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
| TW201821093A (en) | 2016-07-13 | 2018-06-16 | 英商４Ｄ製藥有限公司 | Compositions comprising bacterial strains |
| US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
| US11213549B2 (en) | 2016-10-11 | 2022-01-04 | Finch Therapeutics Holdings Llc | Compositions and method for treating primary sclerosing cholangitis and related disorders |
| US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| US11026978B2 (en) | 2016-10-11 | 2021-06-08 | Finch Therapeutics Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
| CN107058490B (en) * | 2017-01-12 | 2018-03-06 | 杨俊杰 | Enteron aisle and the analysis method of oral cavity flora diversity and otherness |
| WO2018187272A1 (en) | 2017-04-03 | 2018-10-11 | Gusto Global, Llc | Rational design of microbial-based biotherapeutics |
| CA3058818A1 (en) | 2017-04-05 | 2018-10-11 | Crestovo Holdings Llc | Compositions and methods for treating parkinson's disease (pd) and related disorders |
| WO2018187464A1 (en) | 2017-04-05 | 2018-10-11 | Crestovo Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
| WO2018195467A1 (en) * | 2017-04-21 | 2018-10-25 | Memorial Sloan-Kettering Cancer Center | Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof |
| WO2018213262A1 (en) | 2017-05-19 | 2018-11-22 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for reducing listeria monocytogenes infection or colonization |
| MA48939B1 (en) | 2017-05-22 | 2021-06-30 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| EP3630942B1 (en) | 2017-05-24 | 2022-11-30 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
| AU2018272048B2 (en) | 2017-05-26 | 2024-04-04 | Finch Therapeutics Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
| RS61210B1 (en) | 2017-06-14 | 2021-01-29 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| JP6837581B2 (en) * | 2017-06-14 | 2021-03-03 | フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ | Compositions Containing Bacterial Strains of the Genus Megasphaera and Their Use |
| IT201700068009A1 (en) * | 2017-06-19 | 2018-12-19 | Probiotical Spa | Composition comprising strains of bacteria belonging to the species Lactobacillus salivarius for the treatment of Parkinson's disease |
| JP2020529478A (en) * | 2017-08-04 | 2020-10-08 | セカンド ゲノム インコーポレイテッド | ROSEBURIA HOMINIS as a biotherapeutic, Eubacterium Eligence, and combinations thereof |
| CA3072032A1 (en) | 2017-08-07 | 2019-02-14 | Finch Therapeutics, Inc. | Compositions and methods for maintaining and restoring a healthy gut barrier |
| CN111212655A (en) | 2017-08-14 | 2020-05-29 | 赛里斯治疗公司 | Compositions and methods for treating cholestatic diseases |
| JP7079320B2 (en) * | 2017-08-29 | 2022-06-01 | ビージーアイ シェンチェン | Application of Alistopes shahii in the preparation of compositions for the prevention and / or treatment of lipid metabolism-related diseases |
| WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | Methods and compositions for treatment of microbiome-associated disorders |
| US10874680B2 (en) | 2017-09-25 | 2020-12-29 | Tata Chemicals Limited | Method of increasing relative abundance of oscillospira |
| US11825862B2 (en) | 2017-10-18 | 2023-11-28 | Native Microbials, Inc. | Fowl production by administration of a synthetic bioensemble of microbes or purified strains thereof |
| MX2020004495A (en) * | 2017-10-30 | 2021-01-08 | Seres Therapeutics Inc | Compositions and methods for treating antibiotic resistance. |
| TW201924701A (en) | 2017-11-29 | 2019-07-01 | 美商通路實業集團國際公司 | Method and topical composition for modification of a skin microbiome |
| WO2019115759A1 (en) * | 2017-12-14 | 2019-06-20 | Københavns Universitet | Bacterial compositions and the use thereof for the treatment or prevention of asthma or other wheezing disorders or allergy in a child |
| JP2021519299A (en) * | 2018-03-28 | 2021-08-10 | セレス セラピューティクス インコーポレイテッド | Treatment of cancer by microbial flora modulation |
| EP3773645A4 (en) | 2018-04-10 | 2021-11-24 | Siolta Therapeutics, Inc. | Microbial consortia |
| CA3098971A1 (en) | 2018-05-11 | 2019-11-14 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| WO2019226035A1 (en) * | 2018-05-25 | 2019-11-28 | 주식회사 엠디헬스케어 | Method for diagnosing colon cancer through qpcr analysis |
| JP7126004B2 (en) * | 2018-05-31 | 2022-08-25 | ビージーアイ シェンチェン | Composition and use thereof |
| US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
| CN108815199B (en) * | 2018-08-03 | 2021-10-01 | 南华大学 | Application of mouse chlamydia in preparation of anti-ulcerative colitis medicine |
| KR20210065969A (en) | 2018-09-27 | 2021-06-04 | 핀치 테라퓨틱스 홀딩스 엘엘씨 | Compositions and methods for treating epilepsy and related disorders |
| US20220054560A1 (en) * | 2018-10-15 | 2022-02-24 | Pharmabiome Ag | Consortia of living bacteria useful for treatment of colorectal cancer |
| AU2019376669A1 (en) * | 2018-11-09 | 2021-06-10 | The Brigham And Women's Hospital, Inc. | Therapeutic microbiota for the treatment and/or prevention of dysbiosis |
| WO2020149719A2 (en) * | 2019-01-18 | 2020-07-23 | 주식회사 천랩 | Irritable bowel syndrome-specific microbial biomarker, and method for predicting risk of irritable bowel syndrome by using same |
| WO2021041981A1 (en) * | 2019-08-28 | 2021-03-04 | Assembly Biosciences, Inc. | Compositions comprising bacterial species and methods related thereto |
| CN112438995A (en) | 2019-09-04 | 2021-03-05 | 台达电子工业股份有限公司 | Probiotics for inhibiting vancomycin-resistant enterococci, combination and application thereof |
| CN114786690A (en) | 2019-10-07 | 2022-07-22 | 谢尔塔治疗公司 | Therapeutic pharmaceutical composition |
| EP3808358A1 (en) * | 2019-10-17 | 2021-04-21 | University College Cork-National University of Ireland, Cork | Microbial compositions, strains and methods |
| WO2021146639A1 (en) * | 2020-01-17 | 2021-07-22 | Second Genome, Inc. | Methods and compositions for treating colorectal cancer |
| WO2021167609A1 (en) * | 2020-02-18 | 2021-08-26 | Xia Xin Rui | Method for treating and preventing coronavirus (covid-19) infection by direct pulmonary administration of a selected microorganism |
| RU2743696C1 (en) * | 2020-03-03 | 2021-02-24 | федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный университет" (КемГУ) | Method of producing capsular form of antimicrobial agent for treating gastrointestinal disorders |
| TW202203950A (en) * | 2020-03-30 | 2022-02-01 | 香港商香港微生物菌群創新中心有限公司 | Use of microorganisms in regulation of bodyweight and cholesterol level |
| CN111440884B (en) * | 2020-04-22 | 2021-03-16 | 中国医学科学院北京协和医院 | Intestinal flora for diagnosing sarcopenia and application thereof |
| KR102177180B1 (en) * | 2020-05-13 | 2020-11-10 | 순천대학교 산학협력단 | Novel Treponema phagedenis and method for isolating the same |
| KR102177181B1 (en) * | 2020-05-14 | 2020-11-10 | 순천대학교 산학협력단 | Medium composition for cultivation of reponema phagedenis and uses thereof |
| EP4157297A4 (en) | 2020-05-28 | 2024-04-10 | Trench Therapeutics Inc | Airway medicaments |
| WO2022036225A1 (en) | 2020-08-14 | 2022-02-17 | Prolacta Bioscience, Inc. | Human milk oligosaccharide compositions for use with bacteriotherapies |
| CN111893077A (en) * | 2020-08-24 | 2020-11-06 | 河南金百合生物科技股份有限公司 | Large-scale production method of clostridium butyricum |
| CA3191832A1 (en) * | 2020-09-11 | 2022-03-17 | Jothi Amaranath Govindan | Methods and uses of microbiome compositions |
| EP4228665A1 (en) * | 2020-10-14 | 2023-08-23 | Dermbiont, Inc. | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with fungi and other pathogenic microbes |
| CN112322557A (en) * | 2020-12-07 | 2021-02-05 | 中诚国联（河南）生物科技有限公司 | Multifunctional compound microbial agent and preparation method and application thereof |
| WO2022125785A1 (en) * | 2020-12-10 | 2022-06-16 | Boost Biomes, Inc. | Use of selectable or detectable markers to identify interactions within a microbial community |
| CN113549671B (en) * | 2021-07-21 | 2023-09-08 | 连云港市第一人民医院 | Intestinal flora for diagnosing sarcopenia of maintenance hemodialysis patient |
| CN114591879B (en) * | 2022-05-11 | 2022-12-06 | 中国农业大学 | Lactobacillus fermentum for inhibiting helicobacter pylori and application thereof |
| CN116067612B (en) * | 2023-04-06 | 2023-06-23 | 中国航空工业集团公司沈阳空气动力研究所 | Method for realizing transition position observation of flow of large supersonic wind tunnel by sublimation method |
| CN117070416B (en) * | 2023-08-28 | 2024-02-23 | 中国科学技术大学 | Clostridium praecox capable of relieving bulimia nervosa and application thereof |
| CN117286078B (en) * | 2023-11-21 | 2024-02-02 | 四川厌氧生物科技有限责任公司 | Lactobacillus plantarum for improving gastrointestinal health and application thereof |
| CN117797176A (en) * | 2024-03-01 | 2024-04-02 | 南京大学 | Application of clostridium bifidum in preparation of medicine for treating non-alcoholic fatty liver disease and medicine |
Family Cites Families (154)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3009864A (en) | 1958-09-18 | 1961-11-21 | Union Carbide Corp | Process control |
| US3228838A (en) | 1959-04-23 | 1966-01-11 | Union Carbide Corp | Preservation of biological substances |
| US3009861A (en) | 1961-01-13 | 1961-11-21 | Alderton Gordon | Isolation of bacterial spores |
| US3608030A (en) | 1969-05-21 | 1971-09-21 | Howard Tint | Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations |
| US4077227A (en) | 1976-11-12 | 1978-03-07 | Regents Of The University Of Minnesota | Method of freezing liquid material in which agglomeration is inhibited |
| US4205132A (en) | 1978-07-17 | 1980-05-27 | Microlife Technics, Inc. | Lyophilization of bacteria |
| FI59925C (en) | 1980-01-11 | 1981-11-10 | Esko Viljo Nurmi | FOERFARANDE FOER FRAMSTAELLNING AV ETT BAKTERIEPREPARAT ANVAENDBART FOER FOERHINDRANDE AV SALMONELLAINFEKTION HOS FJAEDERFAE |
| US4655047A (en) | 1985-03-25 | 1987-04-07 | I.Q.F. Inc. | Process for freezing or chilling |
| JPS61252212A (en) | 1985-04-12 | 1986-11-10 | Mitsubishi Petrochem Co Ltd | Production of highly water-absorptive polymer |
| US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
| US5196205A (en) | 1987-10-12 | 1993-03-23 | Borody Thomas J | Method for treatment of gastro intestinal disorders |
| US5045446A (en) | 1988-08-26 | 1991-09-03 | Cryopharm Corporation | Lyophilization of cells |
| ATE165738T1 (en) | 1988-08-02 | 1998-05-15 | Gastro Services Pty Ltd | TREATMENT OF GASTRO-INTESTINAL DISEASES |
| US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
| GB2233343B (en) | 1989-06-30 | 1993-07-07 | Farmos Oy | A bacterial preparation for use in poultry |
| JP2961182B2 (en) * | 1990-03-09 | 1999-10-12 | ミヤリサン株式会社 | Pharmaceutical composition for prevention and treatment of Clostridium difficile diarrhea and pseudomembranous colitis |
| JP2961184B2 (en) | 1990-05-07 | 1999-10-12 | ミヤリサン株式会社 | Pharmaceutical composition for prevention and treatment of Clostridium difficile diarrhea and pseudomembranous colitis |
| US5436002A (en) | 1991-01-29 | 1995-07-25 | Mycogen Corporation | Bacillus thuringiensisisolate PS201T6 toxin |
| RU2035186C1 (en) | 1992-07-09 | 1995-05-20 | Семен Рафаилович Резник | Prophylactic biopreparation sporolact |
| WO1994008598A1 (en) | 1992-10-09 | 1994-04-28 | Advanced Tissue Sciences, Inc. | Liver reserve cells |
| US5599795A (en) | 1994-08-19 | 1997-02-04 | Mccann; Michael | Method for treatment of idiopathic inflammatory bowel disease (IIBD) |
| WO1997008598A1 (en) | 1995-08-25 | 1997-03-06 | Gff Technopark | Simultaneous, phase-sensitive digital detection process for time-resolved, quasi-simultaneously captured data arrays of a periodically stimulated system |
| CA2232001C (en) | 1995-09-15 | 2002-12-10 | Dale N. Gerding | Methods and compositions for prevention and treatment of clostridium difficile-associated diseases |
| AUPO430496A0 (en) | 1996-12-19 | 1997-01-23 | Arnott's Biscuits Limited | Prebiotics and probiotics |
| US5965128A (en) | 1997-08-13 | 1999-10-12 | University Of Georgia Research Foundation Inc. | Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli |
| US5951977A (en) | 1997-10-14 | 1999-09-14 | The United States Of America, As Represented By The Secretary Of Agriculture | Competitive exclusion culture for swine |
| US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
| US6589771B1 (en) | 1999-10-28 | 2003-07-08 | Immunom Technologies, Inc. | Methods for arousing dormant bacteria |
| US20030118547A1 (en) | 2000-01-27 | 2003-06-26 | Vandenberg Grant William | Composition for intestinal delivery |
| US6613549B2 (en) | 2000-02-10 | 2003-09-02 | Urex Biotech, Inc. | Probiotic therapy for newborns |
| US20020013270A1 (en) * | 2000-06-05 | 2002-01-31 | Bolte Ellen R. | Method for treating a mental disorder |
| US20040170617A1 (en) | 2000-06-05 | 2004-09-02 | Finegold Sydney M. | Method of treating diseases associated with abnormal gastrointestinal flora |
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| JP4410992B2 (en) | 2000-11-30 | 2010-02-10 | ザ バイオ バランス コーポレイション | Bacterial strains, treated plant extracts, compositions containing them, methods for their preparation, and their therapeutic and industrial applications |
| CN1678735A (en) | 2001-05-04 | 2005-10-05 | 佛罗里达大学研究基金会有限公司 | Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor |
| ITMI20011632A1 (en) | 2001-07-27 | 2003-01-27 | Sanofi Synthelabo | SOLID COMPOSITION CONTAINING SPORE OF NON-PATHOGENIC BACTERIA OF THE GENERAL BACILLUS |
| GB0130789D0 (en) | 2001-12-21 | 2002-02-06 | King S College London | Application of spores |
| US8383342B2 (en) | 2002-04-24 | 2013-02-26 | The University Of North Carolina At Greensboro | Compositions, products, methods and systems to monitor water and other ecosystems |
| GB0212975D0 (en) | 2002-06-06 | 2002-07-17 | Mars Uk Ltd | Mammalian animal composition |
| AU2002951692A0 (en) | 2002-09-23 | 2002-10-17 | Vital Biotech (Hong Kong) Limited | Improvements in or relating to vaccines |
| WO2004069156A2 (en) | 2003-01-30 | 2004-08-19 | The Regents Of The University Of California | Inactivated probiotic bacteria and methods of use thereof |
| US8617870B2 (en) | 2003-03-13 | 2013-12-31 | University Of Ottawa | Antioxidant producing bacterium and uses thereof |
| EP1631312B1 (en) | 2003-04-23 | 2008-09-10 | Medarex, Inc. | Compositions and methods for the therapy of inflammatory bowel disease |
| EP1473370A3 (en) | 2003-04-24 | 2005-03-09 | BioMerieux, Inc. | Genus, group, species and/or strain specific 16S rDNA Sequences |
| WO2004104175A2 (en) | 2003-05-14 | 2004-12-02 | University Of Georgia Research Foundation, Inc. | Probiotic bacteria and methods |
| MXPA06001821A (en) | 2003-08-18 | 2006-05-31 | Bio Balance Corp | A stable liquid probiotic composition, preparation and applications thereof. |
| US20050048515A1 (en) | 2003-08-29 | 2005-03-03 | Garner Bryan E. | Methods for detecting and quantifying specific probiotic microorganisms in animal feed |
| US7731976B2 (en) | 2003-08-29 | 2010-06-08 | Cobb And Company, Llp | Treatment of irritable bowel syndrome using probiotic composition |
| US20050239706A1 (en) | 2003-10-31 | 2005-10-27 | Washington University In St. Louis | Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| DK1715755T3 (en) | 2004-02-03 | 2015-03-09 | Prevtec Microbia Inc | Use of live bacteria to promote growth in animals |
| US7632520B2 (en) | 2004-02-16 | 2009-12-15 | Sanjeev Khandelwal | Synergistic antibacterial formulation and to a method of making the same |
| US7854927B2 (en) | 2004-05-11 | 2010-12-21 | Ganeden Biotech, Inc. | Methods and compositions for the dietary management of autoimmune disorders |
| ES2523316T3 (en) | 2004-11-01 | 2014-11-24 | Erber Aktiengesellschaft | Bacteriophages as selective agents |
| EP2280085A3 (en) | 2004-11-01 | 2011-02-23 | George Mason University | Compositions and methods for diagnosing colon disorders |
| US20060188523A1 (en) | 2005-01-10 | 2006-08-24 | Zhiheng Pei | Methods for diagnosing and treating chronic tonsillitis |
| US7993667B2 (en) | 2005-03-25 | 2011-08-09 | Kimberly-Clark Worldwide, Inc. | Methods of manufacturing a medicated tampon assembly |
| CA2607949C (en) | 2005-05-31 | 2012-09-25 | Thomas William-Maxwell Boileau | Feline probiotic bifidobacteria |
| US7452872B2 (en) | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
| AU2006296837B2 (en) | 2005-09-28 | 2012-12-13 | Nordic Rebalance A/S | Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors |
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| WO2007136553A2 (en) | 2006-05-18 | 2007-11-29 | Biobalance Llc | Bacterial strains, compositions including same and probiotic use thereof |
| JP5019563B2 (en) | 2006-06-16 | 2012-09-05 | 旭化成ケミカルズ株式会社 | Intestinal bacteria activator |
| JP2009541298A (en) | 2006-06-20 | 2009-11-26 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Electronic capsule for treating gastrointestinal disorders |
| TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| EE05459B1 (en) | 2006-12-08 | 2011-08-15 | Tartu �likool | Use of the sporogenic Bacillus smithii or TBMI12 MSCL P737 and its endospores as probiotic, nutritional supplement and probiotic composition |
| WO2008076696A2 (en) | 2006-12-18 | 2008-06-26 | Washington University In St. Louis | The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder |
| DE102006062250A1 (en) | 2006-12-22 | 2008-06-26 | Roland Saur-Brosch | Use of a composition of minerals and / or vitamins and optionally acetogenic and / or butyrogenic bacteria for oral or rectal administration for the treatment and prevention of abdominal discomfort |
| WO2008083157A2 (en) | 2006-12-29 | 2008-07-10 | Washington University In St. Louis | Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject |
| CA2699550C (en) | 2007-09-12 | 2020-08-18 | Targanta Therapeutics Corp. | Method of inhibiting clostridium difficile by administration of oritavancin |
| US8236508B2 (en) | 2008-01-29 | 2012-08-07 | Drexel University | Detecting and measuring live pathogens utilizing a mass detection device |
| US8021654B2 (en) | 2008-03-14 | 2011-09-20 | Danisco A/S | Methods of treating pigs with Bacillus strains |
| KR20100134080A (en) | 2008-04-01 | 2010-12-22 | 메타메트릭스 클리니칼 레보러토리 | Process and method for monitoring gastrointestinal microbiota |
| CN102940652B (en) | 2008-05-28 | 2015-03-25 | 青岛东海药业有限公司 | Eubacterium biforme preparation and use thereof |
| EP2313773A1 (en) | 2008-07-15 | 2011-04-27 | Metanomics Health GmbH | Means and methods diagnosing gastric bypass and conditions related thereto |
| CN102131928A (en) | 2008-08-26 | 2011-07-20 | 奥林巴斯株式会社 | Method for preparing fecal sample, fecal sample preparation solution, and feces collection kit |
| WO2010030997A1 (en) | 2008-09-12 | 2010-03-18 | The Washington University | Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss |
| US9603876B2 (en) | 2008-09-25 | 2017-03-28 | New York University | Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment |
| US9340569B2 (en) | 2008-11-03 | 2016-05-17 | Tufts University | Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth |
| GB0821913D0 (en) | 2008-12-02 | 2009-01-07 | Price & Co | Antibacterial compounds |
| IT1393931B1 (en) | 2009-02-25 | 2012-05-17 | Neuroscienze Pharmaness S C A R L | COMPOSITION OF SPORE OF NON-PATHOGENIC BACTERIA |
| US20120128633A1 (en) | 2009-04-30 | 2012-05-24 | Campagnie Gervaise Donone | Use of collinsella aerofaciens for reducing bloating |
| ES2578081T5 (en) | 2009-05-01 | 2019-10-16 | Uas Laboratories Llc | Bacterial compositions for prophylaxis and treatment of degenerative diseases |
| US9050276B2 (en) | 2009-06-16 | 2015-06-09 | The Trustees Of Columbia University In The City Of New York | Autism-associated biomarkers and uses thereof |
| US20120264637A1 (en) | 2009-06-26 | 2012-10-18 | The Regents Of The University Of California | Methods and systems for phylogenetic analysis |
| US20120165215A1 (en) | 2009-06-26 | 2012-06-28 | The Regents Of The University Of California | Methods and systems for phylogenetic analysis |
| WO2011005756A1 (en) | 2009-07-06 | 2011-01-13 | Puretech Ventures, Llc | Delivery of agents targeted to microbiota niches |
| CA2770099A1 (en) | 2009-08-18 | 2011-02-24 | Nestec S.A. | A nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children. |
| WO2011022542A2 (en) | 2009-08-19 | 2011-02-24 | Puretech Ventures, Llc | Administration of factors normally present in a microbial niche to improve health |
| WO2011022660A1 (en) | 2009-08-21 | 2011-02-24 | Puretech Ventures, Llc | Methods of diagnosing and treating microbiome-associated disease using interaction network parameters |
| GB0916335D0 (en) | 2009-09-17 | 2009-10-28 | Martin W J | Medicaments |
| EP2480255B1 (en) | 2009-09-23 | 2017-11-22 | Thomas Julius Borody | Therapy for chronic enteric infections |
| CA2776420A1 (en) | 2009-10-05 | 2011-04-14 | Aak Patent B.V. | Methods for diagnosing irritable bowel syndrome |
| US20110081320A1 (en) | 2009-10-06 | 2011-04-07 | Nubiome, Inc. | Treatment/Cure of Autoimmune Disease |
| WO2011046616A2 (en) | 2009-10-15 | 2011-04-21 | New York University | Methods for modulating bacterial infection |
| RU2012123959A (en) | 2009-11-12 | 2013-12-20 | Нестек С.А. | NUTRITIONAL COMPOSITION PROMOTING A MICROBIOTIC BALANCE AND IMPROVING A HEALTHY IMPACT ON HEALTH |
| CA2785658C (en) | 2009-12-31 | 2017-10-24 | Ira Milton Trachtman | Compositions and method for treatment and prophylaxis of inflammatory bowel disease |
| EP3181684B1 (en) | 2010-02-01 | 2019-05-29 | Rebiotix Inc. | Bacteriotherapy for clostridium difficile colitis |
| US9492487B2 (en) | 2010-02-01 | 2016-11-15 | Matthew Ryan Garner | Microbial product containing multiple microorganisms |
| US20130230498A1 (en) | 2010-02-16 | 2013-09-05 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities |
| NZ602704A (en) | 2010-03-01 | 2015-01-30 | Agronomique Inst Nat Rech | Method of diagnostic of inflammatory bowel diseases |
| WO2011107482A2 (en) | 2010-03-01 | 2011-09-09 | Institut National De La Recherche Agronomique | Method of diagnostic of obesity |
| IT1398553B1 (en) | 2010-03-08 | 2013-03-01 | Probiotical Spa | COMPOSITION INCLUDING PROBIOTIC BACTERIA FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH THE ALTERATION OF THE IMMUNE SYSTEM. |
| WO2011113801A1 (en) | 2010-03-16 | 2011-09-22 | Universiteit Gent | Use of clostridium perfringens strain 23 to protect against necrotic enteritis |
| US8951512B2 (en) | 2010-05-04 | 2015-02-10 | New York University | Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota |
| WO2011151941A1 (en) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | Composition having activity of inducing proliferation or accumulation of regulatory t cell |
| WO2012006369A2 (en) | 2010-07-06 | 2012-01-12 | Novartis Ag | Immunisation of large mammals with low doses of rna |
| US9005601B2 (en) | 2010-07-16 | 2015-04-14 | The Board Of Trustees Of The University Of Arkansas | Methods and compositions including spore-forming bacteria for increasing the health of animals |
| FI20105825A (en) * | 2010-07-26 | 2012-01-27 | Suomen Punainen Risti Veripalvelu | Use of blood group status III |
| NZ607043A (en) | 2010-08-04 | 2015-05-29 | Borody Thomas J | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
| US9386793B2 (en) | 2010-08-20 | 2016-07-12 | New York University | Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota |
| AU2011299285B2 (en) | 2010-09-10 | 2017-01-05 | Ntcd, Llc | Environmental Clostridial bacteriotherapy and related formulations and methods of manufacture and use |
| EP2646567A4 (en) | 2010-10-04 | 2014-03-26 | British Columbia Cancer Agency | Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer |
| US8802099B2 (en) | 2010-11-10 | 2014-08-12 | National Jewish Health | Methods to treat allergic conditions |
| US20120064592A1 (en) | 2011-01-26 | 2012-03-15 | Qteros, Inc. | Biocatalysts synthesizing deregulated cellulases |
| WO2012108830A1 (en) | 2011-02-09 | 2012-08-16 | Lavivo Ab | Synbiotic compositions for restoration and reconstitution of gut microbiota |
| WO2012116289A2 (en) | 2011-02-25 | 2012-08-30 | Tricorder Diagnostics, Llc | Microbial signatures as indicators of radiation exposure |
| WO2012122478A1 (en) | 2011-03-09 | 2012-09-13 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
| WO2012122522A2 (en) | 2011-03-09 | 2012-09-13 | Washington University | Cultured collection of gut microbial community |
| WO2012142605A1 (en) * | 2011-04-15 | 2012-10-18 | Samaritan Health Services | Rapid recolonization deployment agent |
| US20120276056A1 (en) | 2011-04-26 | 2012-11-01 | Wieslaw Janusz Bochenek | Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine |
| WO2012159023A2 (en) | 2011-05-19 | 2012-11-22 | Virginia Commonwealth University | Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction |
| US9579353B2 (en) | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
| WO2013008102A2 (en) | 2011-07-14 | 2013-01-17 | R.E.D. Laboratories N.V../ S.A. | Methods and compositions for evaluating and/or treating chronic immune diseases |
| US20130022575A1 (en) | 2011-07-19 | 2013-01-24 | Microbial Rx | Systems and methods of replacing intestinal flora |
| US20140348811A1 (en) | 2011-07-27 | 2014-11-27 | Max International, Llc | Compositions comprising sugar-cysteine products |
| WO2013019896A1 (en) | 2011-08-01 | 2013-02-07 | Symbiotix Biotherapies, Inc. | Platform for identifying and/or characterizing immunomodulatory agents |
| JP6116568B2 (en) | 2011-08-30 | 2017-04-19 | アカデミッシュ メディッシュ セントラム | Method for preventing and / or treating insulin resistance |
| US20140342438A1 (en) | 2011-09-14 | 2014-11-20 | University Of Guelph | Media supplements and methods to culture human gastrointestinal anaerobic microorganisms |
| US20130121968A1 (en) | 2011-10-03 | 2013-05-16 | Atossa Genetics, Inc. | Methods of combining metagenome and the metatranscriptome in multiplex profiles |
| US20130115232A1 (en) | 2011-10-03 | 2013-05-09 | Fred Hutchinson Cancer Research Center | Methods for detecting graft-versus-host disease |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| EP2750682B1 (en) | 2011-10-11 | 2016-05-18 | Achim Biotherapeutics AB | Composition comprising anaerobically cultivated human intestinal microbiota |
| EP3978598A1 (en) | 2011-12-01 | 2022-04-06 | The University of Tokyo | Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
| GB201201766D0 (en) | 2012-02-01 | 2012-03-14 | Imp Innovations Ltd | Method |
| WO2013166031A1 (en) | 2012-04-30 | 2013-11-07 | The Washington University | Method of isolating and characterizing microorganisms that are targets of host immune responses |
| US10130665B2 (en) | 2012-05-18 | 2018-11-20 | Genome Research Limited | Method for identifying bacteria for bacteriotherapy |
| CA3172599A1 (en) | 2012-05-25 | 2013-11-28 | Sloan Kettering Institute For Cancer Research | Anti-ceramide antibody and antigen binding fragment thereof |
| US9719144B2 (en) | 2012-05-25 | 2017-08-01 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
| EP2684469A1 (en) | 2012-07-13 | 2014-01-15 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| EP3628161B1 (en) | 2012-11-23 | 2023-04-05 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| EP3904502A3 (en) | 2013-02-04 | 2022-02-23 | Seres Therapeutics, Inc. | Compositions and methods |
| CN110917220A (en) | 2013-02-04 | 2020-03-27 | 赛里斯治疗公司 | Therapeutic compositions and methods of use thereof |
| EP2971148A4 (en) | 2013-03-14 | 2016-08-17 | Seres Therapeutics Inc | Methods for pathogen detection and enrichment from materials and compositions |
| AU2014232370B2 (en) | 2013-03-15 | 2018-11-01 | Seres Therapeutics, Inc. | Network-based microbial compositions and methods |
| CN105142654B (en) | 2013-05-03 | 2020-04-10 | 雀巢产品有限公司 | Lachnospiraceae in the gut microbiota and correlation with body weight |
| WO2015018307A1 (en) | 2013-08-06 | 2015-02-12 | Bgi Shenzhen Co., Limited | Biomarkers for colorectal cancer |
| RU2722482C2 (en) | 2013-11-25 | 2020-06-01 | Серес Терапеутикс, Инк. | Synergistic bacterial compositions and methods for preparing and using them |
| US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| MA41020A (en) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND THEIR METHODS OF USE FOR MODULATION OF THE MICROBIOME |
| AU2016359178A1 (en) | 2015-11-24 | 2018-06-14 | Seres Therapeutics, Inc. | Designed bacterial compositions |
| CN109715177A (en) | 2016-03-14 | 2019-05-03 | 赫罗微生物群公司 | Alimentary canal microorganism group is adjusted to treat mental disease or central nervous system disease |
| MX2020004495A (en) | 2017-10-30 | 2021-01-08 | Seres Therapeutics Inc | Compositions and methods for treating antibiotic resistance. |
-
2014
- 2014-11-25 RU RU2016125316A patent/RU2722482C2/en active
- 2014-11-25 JP JP2016554834A patent/JP6833514B2/en active Active
- 2014-11-25 CA CA3203756A patent/CA3203756A1/en active Pending
- 2014-11-25 AU AU2014352643A patent/AU2014352643A1/en not_active Abandoned
- 2014-11-25 MX MX2016006708A patent/MX367109B/en active IP Right Grant
- 2014-11-25 KR KR1020167017068A patent/KR102379658B1/en active IP Right Grant
- 2014-11-25 KR KR1020237010247A patent/KR102611070B1/en active IP Right Grant
- 2014-11-25 CN CN201480073118.5A patent/CN105979952B/en active Active
- 2014-11-25 EP EP14821918.1A patent/EP3074027A1/en active Pending
- 2014-11-25 CN CN202210285055.6A patent/CN116370507A/en active Pending
- 2014-11-25 WO PCT/US2014/067491 patent/WO2015077794A1/en active Application Filing
- 2014-11-25 CA CA2931317A patent/CA2931317C/en active Active
- 2014-11-25 BR BR112016011830A patent/BR112016011830A2/en not_active Application Discontinuation
- 2014-11-25 US US15/039,007 patent/US10258655B2/en active Active
- 2014-11-25 KR KR1020227009538A patent/KR102515850B1/en active IP Right Grant
-
2016
- 2016-05-23 MX MX2019009132A patent/MX2019009132A/en unknown
-
2018
- 2018-12-21 US US16/230,807 patent/US11266699B2/en active Active
-
2020
- 2020-12-03 JP JP2020201020A patent/JP7473285B2/en active Active
-
2021
- 2021-01-18 AU AU2021200287A patent/AU2021200287B2/en active Active
-
2022
- 2022-01-28 US US17/588,122 patent/US11918612B2/en active Active
-
2023
- 2023-08-24 AU AU2023219938A patent/AU2023219938A1/en active Pending
- 2023-12-21 JP JP2023216227A patent/JP2024038027A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11167018B2 (en) | 2016-12-23 | 2021-11-09 | Keio University | Compositions and methods for the induction of CD8+ T-cells |
| US11633465B2 (en) | 2016-12-23 | 2023-04-25 | Keio University | Compositions and methods for the induction of CD8+ T-cells |
| US11723934B2 (en) | 2018-02-09 | 2023-08-15 | Keio University | Compositions and methods for the induction of CD8+ T-cells |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112016011830A2 (en) | synergistic bacterial compositions and methods for their production and use. | |
| LTC3057969I2 (en) | COMPOSITIONS USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH KIT | |
| NO2023013I1 (en) | Combination of foslevodopa and foscarbidopa, each in all forms protected by the basic patent | |
| BR112015023310A2 (en) | lipid lowering compositions, methods and kits | |
| BR112017015944A2 (en) | oligosaccharide compositions for use in animal feed and methods for producing them | |
| BR112016021626A2 (en) | 5-substituted indazol-3-carboxamides and their preparation and use | |
| BR112015030972A2 (en) | sc-beta cells and compositions and methods for generating them | |
| BR112015023679A2 (en) | immunotherapy compositions and methods | |
| DK3230281T3 (en) | 1,3-THIAZOL-2-YL-SUBSTITUTED BENZAMIDES | |
| BR112016018521A2 (en) | composition and kit. | |
| BR112015028459A2 (en) | compositions and edibles | |
| DK2943549T3 (en) | SYNERGISTIC H2S-SCAVENGER COMPOSITION | |
| DK3122294T5 (en) | OCLUSION RAIL FURNITURE | |
| BR112014031412A2 (en) | method of preparing a composition, composition and its use, and kit. | |
| CL2016001153A1 (en) | Fish vaccine | |
| FR3002452B1 (en) | TOPIC ANTIMICROBIAL DERMATOLOGICAL COMPOSITION | |
| BR112015023965A2 (en) | composition for oral hygiene. | |
| BR112017001384A2 (en) | compound for use in anthelmintic treatment | |
| BR112016021875A2 (en) | topical composition | |
| DK3288536T3 (en) | COMPOSITIONS COMPREHENSIVE ANAKINRA | |
| BR112017002672A2 (en) | flavor barrier composition. | |
| BR112016008035A2 (en) | composition, use of composition | |
| DK3057450T3 (en) | FOOD COMPOSITION | |
| ES1078864Y (en) | FOLDER-TRANSPORTABLE CHAIR. | |
| ES1078553Y (en) | CONSTRUCTION BLOCK |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |